date founded

General

About Company
Crescent Innovations develops nonsurgical therapies using biologically compatible polymers.

Industry

Sector :

Subsector :

founded date

01.01.2001

Number of employees

Company Type

For Profit

IPO status

Private

Description

Massachusetts-based Crescent Innovations is an early-stage medical product company specializing in the research and development of biologically compatible polymers. Their focus is on creating regenerative therapies for chronic and acute pain, with a particular emphasis on osteoarthritis. Their advanced candidate for treating osteoarthritis has the potential to be more effective, less expensive, and require fewer treatments compared to traditional therapies. Additionally, Crescent Innovations has developed an injectable medical device that improves the quality of life for individuals suffering from jaw joint pain. Unlike similar devices that use manufacturing processes involving pathogens, Crescent Innovations' revolutionary process eliminates the use of pathogens, resulting in improved efficacy and reduced manufacturing costs.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Synedgen

Synedgen

Synedgen develops novel therapies and products to reduce infection and inflammation of dermal, oral, mucosal, and ophthalmic surfaces.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Claremont, CA, USA

total rounds

6

total raised

$20.29M
Techulon

Techulon

Techulon creates and sells custom polymers for research, with a focus on ionic bio-polymers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Blacksburg, VA, USA

total rounds

5

total raised

$2.05M
Carmell Therapeutics

Carmell Therapeutics

Carmell develops biologically-active plastics from blood plasma for treating bone and connective tissue injuries.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

Pittsburgh, PA, USA

total rounds

15

total raised

$12.04M
Orthox Ltd.

Orthox Ltd.

Orthox is developing tissue regenerative implants to treat cartilage injuries.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

Abingdon, UK

total rounds

15

total raised

$38.12M

Financials

Co-Investors

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week